title: Benefits/risks of syrup of ipecac.
abstract: The status of syrup of ipecac as a nonprescription drug has helped reduce the death rate in children, ages 1 to 5 years. The drug has proven safe and effective in children in the recommended doses. To deprive parents of ready access to ipecac syrup would result in increased disability and death from poisoning and more emergency department visits.
authors.forename: H C
authors.initials: HC
authors.lastname: Mofenson
authors.forename: T R
authors.initials: TR
authors.lastname: Caraccio
mesh_terms: D000293:Adolescent; D000856:Anorexia Nervosa / Q000139:chemically induced; D002648:Child; D006801:Humans; D006963:Hyperphagia / Q000139:chemically induced; D007486:Ipecac / Q000009:adverse effects / Q000627:therapeutic use*; D004366:Nonprescription Drugs; D011041:Poisoning / Q000188:drug therapy*; D012449:Safety
chemical_list: D004366:Nonprescription Drugs; D007486:Ipecac